Jeremy Millar
Jeremy Millar
Alfred Health
Verifierad e-postadress på monash.edu
Titel
Citeras av
Citeras av
År
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
9822005
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ...
The lancet oncology 8 (6), 475-487, 2007
9412007
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results …
P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ...
BJU international 109, 22-29, 2012
4712012
Activation of thymic regeneration in mice and humans following androgen blockade
JS Sutherland, GL Goldberg, MV Hammett, AP Uldrich, SP Berzins, ...
The Journal of Immunology 175 (4), 2741-2753, 2005
4232005
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ...
The lancet oncology 15 (4), 464-473, 2014
3332014
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
JE Sylvester, PD Grimm, JC Blasko, J Millar, PF Orio, S Skoglund, ...
International Journal of Radiation Oncology* Biology* Physics 67 (1), 57-64, 2007
2432007
Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-urinary group
MA Sidhom, AB Kneebone, M Lehman, KL Wiltshire, JL Millar, ...
Radiotherapy and Oncology 88 (1), 10-19, 2008
1442008
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
1282016
Human immunodeficiency virus–related primary central nervous system lymphoma: Factors influencing survival in 111 patients
ME Newell, JF Hoy, SG Cooper, B DeGraaff, AE Grulich, M Bryant, ...
Cancer 100 (12), 2627-2636, 2004
1132004
AP hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early …
M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ...
BJU international 113, 7-12, 2014
1102014
In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation
RE Neal, JL Millar, H Kavnoudias, P Royce, F Rosenfeldt, A Pham, ...
The Prostate 74 (5), 458-468, 2014
932014
A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized respectable cancer of the esophagus
BH Burmeister
Prog Proc Am Soc Clin Oncol 21, 130a, 2002
902002
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
SM Evans, JL Millar, ID Davis, DG Murphy, DM Bolton, GG Giles, ...
Medical journal of Australia 198 (10), 540-545, 2013
872013
The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the V ictorian Prostate Cancer Registry
M Weerakoon, N Papa, N Lawrentschuk, S Evans, J Millar, M Frydenberg, ...
BJU international 115, 50-56, 2015
862015
High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer
DR Zwahlen, N Andrianopoulos, B Matheson, GM Duchesne, JL Millar
Brachytherapy 9 (1), 27-35, 2010
822010
Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors
BR Hindson, JL Millar, B Matheson
Brachytherapy 12 (1), 50-55, 2013
692013
Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer
DR Zwahlen, JD Ruben, P Jones, F Gagliardi, JL Millar, U Schneider
International Journal of Radiation Oncology* Biology* Physics 74 (2), 539-545, 2009
672009
Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer
JJ Tjandra, DM Reading, SA McLachlan, IF Gunn, MD Green, ...
Diseases of the colon & rectum 44 (8), 1113-1122, 2001
652001
Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy
SG Williams, JL Millar, GM Duchesne, MJ Dally, PL Royce, RM Snow
Radiotherapy and oncology 73 (1), 33-38, 2004
622004
Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal
L Lim, M Chao, J Shapiro, JL Millar, D Kipp, A Rezo, A Fong, IT Jones, ...
Diseases of the Colon & Rectum 50 (12), 2032, 2007
602007
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20